Patent · US Active

Combination comprising immunostimulatory oligonucleotides

US10604760B2 · kind B2 · utility

4Cited by

2References

1Claims

0Family size

Assignee

Mologen AG · DE

Inventors

Matthias Schroff · Berlin, DE
Manuel Schmidt · Berlin, DE
Kerstin Kapp · Berlin, DE
Alfredo Zurlo · Berlin, DE

Key dates

Filing date	Jun 26, 2019
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Jun 26, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAGS, CD137(4-1BB) and a non-codiung immuno-modulating DNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.